Who We Are
Alvogen is the next generation pharmaceuticals company. Our business model ensures competitive advantage through focused in-house capabilities and a network of partners for enhanced speed and flexibility. Alvogen currently has commercial operations in 35 countries around the globe, with regional hubs in North America, Romania and Taiwan.
What we do
Purpose driven culture
Our true purpose is to make people’s lives better by producing high quality medicines that help people live longer, healthier and more active lives and making them more accessible.
Alvogen has launched a great number of products that have significantly impacted patients’ lives around the globe and our goal remains to do even more.
Here are some examples of our most recent product launches: In the U.S. this has included successful launches of generic versions of Tamiflu, as well as Exelon for the treatment of Alzheimer’s, while some of the other drugs we’ve been focusing on are Velcade for the treatment of cancer, Copaxone for MS patients and the biosimilar Inflectra launched in the CEE region.
Our purpose-driven culture is essential to our success as a company.
Commitment to Quality
Get in touch
Alvogen Ukraine
02660, Kyiv, 5-I Brovarsky Avenue
Tel: + 38 044 517 75 00